Lilly receives UK marketing authorisation for tirzepatide (Mounjaro) in alternative Kwikpen presentation for two indications
top of page
Browse by category
Search
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Eli Lilly’s tirzepatide...
FDA approves ReShape Lifesciences’ next-generation Lap-Band 2.0 FLEX
The FDA has granted approval of a PMA supplement for ReShape Lifesciences’ next generation, enhanced Lap-Band 2.0 FLEX. According to the...
Lilly's Mounjaro (tirzepatide) receives UK marketing authorisation for weight management
Eli Lilly and Company has granted marketing authorisation (MA) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for...
FDA clears GE HealthCare’s Allia IGS Pulse next generation of image-guided systems
GE HealthCare has gained FDA 510(k) clearance of the Allia IGS Pulse - the latest addition to the company’s image guided system (IGS)...
Rhythm gains Health Canada Approval of IMCIVREE setmelanotide injection for weight management
Health Canada has approved Rhythm Pharmaceuticals’ IMCIVREE (setmelanotide solution for subcutaneous injection) for weight management in...
Endolumik gains FDA approval for fluorescence guided Gastric Calibration Tube
Endolumik’s fluorescence guided Gastric Calibration Tube, which uses near infrared (NIR) light to allow surgeons to more clearly...
NICE recommends semaglutide should be made available in specialist NHS services
The UK’s regulatory body, NICE, has recommended the use of semaglutide (also called Wegovy or Ozempic) alongside a reduced-calorie diet...
Browse by tag
bottom of page